11.19.25 -- We're A Virtual Biotech. CDMOs Should Treat Us As A Priority

Boost your drug development success with Lonza’s upcoming webinar on amorphous solid dispersions (ASDs). Learn how hot melt extrusion (HME) can enhance bioavailability, cut costs, and scale efficiently—backed by real-world lab and pilot trials. Compare HME and spray drying while gaining exclusive insights into Lonza’s advanced capabilities and proven expertise in ASD manufacturing. Don’t miss it! Click here to learn more.

To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.

This report includes expert guidance on navigating development and manufacturing challenges with orphan drugs, with insights on how drug sponsors of all sizes work with CDMOs to achieve their goals.

By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

With explosive demand, expanding indications, and rapid innovation, the GLP-1 revolution is reshaping dealmaking. Here's a practical guide for companies negotiating M&A in this arena.

Explore the unique challenges faced in the formulation development of ocular therapies and how they can be overcome to ensure safe, efficient, and targeted treatments for patients.

Learn about the process conditions and protocols that were chosen as optimization targets and the resulting improvements to ADC production and purification that assessing these parameters provided.

How do biopharma companies solve the common challenge of increasing output while decreasing headcount? Consider these three options: temporary staffing, outsourcing, and insourcing.

Watch to discover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.

Our team of experts can support you in all aspects of scale-up and technology transfer through our state-of-the-art development and manufacturing facility.

Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.

Stop wasting time on trial-and-error methods. With the EZ Level™ Feeder Base Leveling System, you can achieve fast, accurate, and repeatable results — every time.

Navigating the path toward regulatory approval is tough. See how partnering with Societal™ CDMO and leveraging regulatory expertise can empower your organization to achieve its goals.